Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib

Emanuele Ammatuna, Matthijs Eefting, Kirsten van Lom, François Kavelaars, Peter Valk, Ivo Touw

Research output: Contribution to journalArticleAcademicpeer-review

28 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)879-880
Number of pages2
JournalAnnals of Hematology
Issue number5
Publication statusPublished - 2015

Cite this